These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif. Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024 [TBL] [Abstract][Full Text] [Related]
8. Chromatin dynamics at the hTERT promoter during transcriptional activation and repression by c-Myc and Mnt in Xenopus leavis oocytes. Wahlström T; Belikov S; Arsenian Henriksson M Exp Cell Res; 2013 Dec; 319(20):3160-9. PubMed ID: 23860446 [TBL] [Abstract][Full Text] [Related]
9. Analysis of the Max-binding protein MNT in human medulloblastomas. Sommer A; Waha A; Tonn J; Sörensen N; Hurlin PJ; Eisenman RN; Lüscher B; Pietsch T Int J Cancer; 1999 Sep; 82(6):810-6. PubMed ID: 10446446 [TBL] [Abstract][Full Text] [Related]
11. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc. Mauleon I; Lombard MN; Muñoz-Alonso MJ; Cañelles M; Leon J Mol Carcinog; 2004 Feb; 39(2):85-90. PubMed ID: 14750213 [TBL] [Abstract][Full Text] [Related]
12. Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis. Hurlin PJ; Zhou ZQ; Toyo-oka K; Ota S; Walker WL; Hirotsune S; Wynshaw-Boris A EMBO J; 2003 Sep; 22(18):4584-96. PubMed ID: 12970171 [TBL] [Abstract][Full Text] [Related]
13. Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor. Meroni G; Reymond A; Alcalay M; Borsani G; Tanigami A; Tonlorenzi R; Lo Nigro C; Messali S; Zollo M; Ledbetter DH; Brent R; Ballabio A; Carrozzo R EMBO J; 1997 May; 16(10):2892-906. PubMed ID: 9184233 [TBL] [Abstract][Full Text] [Related]
14. Design and properties of a Myc derivative that efficiently homodimerizes. Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157 [TBL] [Abstract][Full Text] [Related]
15. Loss of the Max-interacting protein Mnt in mice results in decreased viability, defective embryonic growth and craniofacial defects: relevance to Miller-Dieker syndrome. Toyo-oka K; Hirotsune S; Gambello MJ; Zhou ZQ; Olson L; Rosenfeld MG; Eisenman R; Hurlin P; Wynshaw-Boris A Hum Mol Genet; 2004 May; 13(10):1057-67. PubMed ID: 15028671 [TBL] [Abstract][Full Text] [Related]
16. CDC6 interacts with c-Myc to inhibit E-box-dependent transcription by abrogating c-Myc/Max complex. Takayama M; Taira T; Iguchi-Ariga SM; Ariga H FEBS Lett; 2000 Jul; 477(1-2):43-8. PubMed ID: 10899308 [TBL] [Abstract][Full Text] [Related]
17. Mnt takes control as key regulator of the myc/max/mxd network. Wahlström T; Henriksson M Adv Cancer Res; 2007; 97():61-80. PubMed ID: 17419941 [TBL] [Abstract][Full Text] [Related]
19. Development and survival of MYC-driven lymphomas require the MYC antagonist MNT to curb MYC-induced apoptosis. Nguyen HV; Vandenberg CJ; Ng AP; Robati MR; Anstee NS; Rimes J; Hawkins ED; Cory S Blood; 2020 Mar; 135(13):1019-1031. PubMed ID: 31978211 [TBL] [Abstract][Full Text] [Related]
20. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh. Naderi S; Blomhoff HK J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]